In this study, a peptide targeting the transferrin receptor (T7 sequence: HAIYPRH) was employed as the carrier to leverage the high expression of transferrin on the blood-brain barrier (BBB) and its overexpression on glioma cells for site-specific drug delivery. This evidence concerns the gene TF and central nervous system cancer.